Affiliation: Mount Sinai School of Medicine
- Longitudinal associations among quality of life and its predictors in patients treated for prostate cancer: the moderating role of ageMichael Diefenbach
Urology and Oncological Sciences, Mount Sinai School of Medicine, New York, NY10029 6574, USA
Psychol Health Med 13:146-61. 2008..Among older patients (>68 years old, n = 192), lower levels of distress were associated with higher levels of functional QOL, and longer expected survival time was associated with better functional and physical QOL...
- Acceptability and preliminary feasibility of an internet/CD-ROM-based education and decision program for early-stage prostate cancer patients: randomized pilot studyMichael A Diefenbach
Mount Sinai School of Medicine, Departments of Urology and Oncological Sciences, Mount Sinai School of Medicine, New York, NY 10029 0751, United States
J Med Internet Res 14:e6. 2012..PIES virtually mirrors a health center to provide patients with information about prostate cancer and its treatment through an intuitive interface, using videos, animations, graphics, and texts...
- Regret of treatment decision and its association with disease-specific quality of life following prostate cancer treatmentMichael A Diefenbach
Department of Urology and Oncological Science, The Mount Sinai Hospital, Mount Sinai School of Medicine, New York, New York 10029, USA
Cancer Invest 25:449-57. 2007..Extensive discussions about disease-specific quality of life should be included when physicians counsel patients about treatment options...
- Beliefs and attitudes about lung cancer screening among smokersSirisha Jonnalagadda
Doris Duke Clinical Research Fellows, UMDNJ Robert Wood Johnson Medical School, New York, NY 10029, USA
Lung Cancer 77:526-31. 2012..Lung cancer screening programs should address these factors to ensure broad participation, particularly among minorities...
- Cancer and patient-physician communicationMichael Diefenbach
Mount Sinai School of Medicine, New York, New York, USA
J Health Commun 14:57-65. 2009..We conclude by delineating new critical areas for future research including peer-to-peer patient communication and the challenges brought on by new technologies...
- Changing patterns of CAM use among prostate cancer patients two years after diagnosis: reasons for maintenance or discontinuationMatthew Porter
Templeton Foundation, New York, NY, USA
Complement Ther Med 16:318-24. 2008....
- Pushed and pulled: the role of affect and cognition in shaping CAM attitudes and behavior among men treated for prostate cancerMatthew C Porter
The HealthCare Chaplaincy, New York, NY, USA
J Health Psychol 14:288-96. 2009..Our results also indicate preliminarily that affect may be more important than cognition in shaping CAM decisions...
- Decision-making strategies for patients with localized prostate cancerMichael A Diefenbach
Department of Population Science, Fox Chase Cancer Center, Philadelphia, PA 19422, USA
Semin Urol Oncol 20:55-62. 2002..These data suggest that unique treatment-related beliefs and affects need to be taken into account during the treatment counseling process. Implications for the development of decision aids are discussed...
- Religion and spirituality among patients with localized prostate cancerNatalie Hamrick
Department of Anesthesia, Indiana University School of Medicine, Indianapolis, Indiana, USA
Palliat Support Care 4:345-55. 2006....
- A multimedia interactive education system for prostate cancer patients: development and preliminary evaluationMichael A Diefenbach
Fox Chase Cancer Center, Division of Population Science, 333 Cottman Ave, Philadelphia, PA 19111 2497, USA
J Med Internet Res 6:e3. 2004..Yet, to make informed treatment choices patients have to learn complicated disease and treatment information that is often fraught with medical and statistical terminology. Thus, patients need accurate and easy-to-understand information...
- Clinical, demographic and psychosocial correlates of complementary and alternative medicine use by men diagnosed with localized prostate cancerMichael A Diefenbach
Division of Population Science, Fox Chase Cancer Center, Cheltenham, PA, USA
J Urol 170:166-9. 2003..We examined complementary and alternative medicine (CAM) use among men who received standard therapy for localized prostate cancer...